{
    "title": "Joy as NICE approves two drugs that will 'transform' the chances of surviving the most dangerous form of skin cancer",
    "url": "https://www.dailymail.co.uk/health/article-2226445/NICE-approves-drugs-transform-chances-surviving-dangerous-form-skin-cancer.html",
    "date": "2012-11-01",
    "keywords": [
        "cancer",
        "treatment",
        "ipilimumab",
        "year",
        "use",
        "nhs",
        "form",
        "vemurafenib",
        "melanoma",
        "average",
        "institute",
        "research",
        "advance",
        "survival",
        "hope",
        "health",
        "nice",
        "zelboraf",
        "share",
        "kind",
        "fund",
        "guidance",
        "joy",
        "mail",
        "gmt",
        "november",
        "email",
        "view",
        "diseaseipilimumab",
        "decision",
        "excellence",
        "minister",
        "david",
        "cameron",
        "bannice",
        "cost",
        "effectiveness",
        "basis",
        "discountipilimumab",
        "course",
        "month",
        "theyre",
        "sun",
        "groundbreaking",
        "device",
        "article",
        "dr",
        "paul",
        "lecturer",
        "oncology",
        "christie",
        "foundation",
        "trial",
        "uk",
        "progress",
        "illness",
        "step",
        "change",
        "management",
        "disease",
        "yervoy",
        "treatmentvemurafenib",
        "roche",
        "braf",
        "gene",
        "half",
        "chemotherapy",
        "monthsboth",
        "england",
        "government",
        "approval",
        "ireland",
        "lorigan",
        "think",
        "patient",
        "power",
        "difference",
        "alan",
        "executive",
        "nhsit",
        "forward",
        "example",
        "newgeneration",
        "support",
        "group",
        "factor",
        "news",
        "time",
        "thing",
        "chance",
        "carole",
        "longson",
        "director",
        "technology",
        "evaluation",
        "centre",
        "condition",
        "carevemurafenib",
        "prognosis",
        "draft"
    ],
    "category": [
        "health"
    ]
}